Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 70 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Cholongitas, Evangelos  [Clear All Filters]
Journal Article
Cholongitas, E., Katsogridakis K., & Dasenaki M. (2009).  Acalculous cholecystitis during the course of acute Epstein-Barr virus infection.. Int J Infect Dis. 13(3), e129-30.
Cholongitas, E., & Ioannidou D. (2009).  Acrocyanosis due to cold agglutinins in a patient with rheumatoid arthritis.. J Clin Rheumatol. 15(7), 375.
Cholongitas, E., Vibhakorn S., Lodato F., & Burroughs A. K. (2010).  Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation.. Liver Int. 30(2), 334-5.
Soulaidopoulos, S., Sinakos E., Dimopoulou D., Vettas C., Cholongitas E., & Garyfallos A. (2017).  Anticholinergic syndrome induced by toxic plants.. World J Emerg Med. 8(4), 297-301.
Cholongitas, E., Goulis J., Arsos G., Birtsou C., Nakouti T., Papadopoulou S., et al. (2013).  Association between ratio of sodium to potassium in random urine samples and renal dysfunction and mortality in patients with decompensated cirrhosis.. Clin Gastroenterol Hepatol. 11(7), 862-7.
Senzolo, M., Cholongitas E., Burra P., Leandro G., Thalheimer U., Patch D., et al. (2009).  beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.. Liver Int. 29(8), 1189-93.
Cholongitas, E., Karatapanis S., Nakouti T., Birtsou C., Skorda L., Kouvelis I., et al. (2012).  Can 24-h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis?. Liver Int. 32(1), 172-3.
Cholongitas, E., Georgousaki C., Spyrou S., & Dasenaki M. (2009).  Ciprofloxacin-induced acute cholestatic hepatitis.. Ann Hepatol. 8(4), 400-1.
Cholongitas, E., Senzolo M., Patch D., Shaw S., O'Beirne J., & Burroughs A. K. (2009).  Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality.. Eur J Gastroenterol Hepatol. 21(7), 744-50.
Cholongitas, E., Spyrou S., Georgousaki C., & Dasenaki M. (2010).  Comment on: Recurrent skin reaction attributable to darbepoetin alfa in a patient with chronic renal failure.. Ren Fail. 32(4), 528.
Cholongitas, E., Ioannidou M., Goulis I., Chalevas P., Ntogramatzi F., Athanasiadou Z., et al. (2017).  Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.. J Gastroenterol Hepatol. 32(1), 191-198.
Xirouchakis, E., Marelli L., Cholongitas E., Manousou P., Calvaruso V., Pleguezuelo M., et al. (2011).  Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis.. Clin J Am Soc Nephrol. 6(1), 84-92.
Vibhakorn, S., Cholongitas E., Kalambokis G., Manousou P., Quaglia A., Marelli L., et al. (2009).  A comparison of four- versus three-pass transjugular biopsy using a 19-G Tru-Cut needle and a randomized study using a cassette to prevent biopsy fragmentation.. Cardiovasc Intervent Radiol. 32(3), 508-13.
Cholongitas, E., Theocharidou E., Vasianopoulou P., Betrosian A., Shaw S., Patch D., et al. (2012).  Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure.. Liver Transpl. 18(4), 405-12.
Cholongitas, E., Calvaruso V., Betrosian A., Senzolo M., Shaw S., O'Beirne J., et al. (2010).  Critically ill patients with cirrhosis and low serum sodium.. J Clin Gastroenterol. 44(7), 523-4; author reply 524-5.
Papatheodoridis, G. V., Cholongitas E., Archimandritis A. J., & Burroughs A. K. (2009).  Current management of hepatitis B virus infection before and after liver transplantation.. Liver Int. 29(9), 1294-305.
Pipili, C., Sfritzeri A., & Cholongitas E. (2009).  Deforming arthropathy in SLE: review in the literature apropos of one case.. Rheumatol Int. 29(10), 1219-21.
Mastrokostas, A., Gavana M., Gkrizioti M., Smyrnakis E., Cholongitas E., Benos A., et al. (2018).  Discrepancies and misconceptions of perceived colorectal cancer screening barriers between primary health professionals and unscreened population. A comparative study in Greece.. J BUON. 23(7), 67-76.
Marelli, L., Xirouchakis E., Kalambokis G., Cholongitas E., Hamilton M. I., & Burroughs A. K. (2011).  Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?. Gut. 60(9), 1224-8.
Makri, E., Cholongitas E., & Tziomalos K. (2016).  Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease.. World J Gastroenterol. 22(41), 9039-9043.
Cholongitas, E., Xirouchakis E., Garcovich M., & Burroughs A. K. (2010).  Evaluation of renal function in patients with cirrhosis.. J Hepatol. 53(3), 589.
Cholongitas, E., Georgousaki C., Spyrou S., & Dasenaki M. (2009).  Generalized convulsions due to sorafenib-induced hypocalcemia.. Indian J Gastroenterol. 28(4), 158-9.
Cholongitas, E., Arsos G., Goulis J., Birtsou C., Haidich A-B., Nakouti T., et al. (2014).  Glomerular filtration rate is an independent factor of mortality in patients with decompensated cirrhosis.. Hepatol Res. 44(10), E145-55.
Kokolakis, G. P., Ioannidou D., Cholongitas E., & Krüger-Krasagakis S. (2010).  Guttate psoriasis occurring on varicella lesions.. J Dermatol. 37(9), 857-9.
Cholongitas, E., Goulis J., Akriviadis E., & Papatheodoridis G. V. (2011).  Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.. Liver Transpl. 17(10), 1176-90.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές